Andrews Liver Salts Effervescent Powder

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 03/05/16

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 10/7/2015
print

Print ViewKeyword Search SPC

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

Address: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

Medical Information Direct Line: 1800 441 442

Company Products

Medicine NameActive Ingredients
Medicine Name Advil Cold and Flu Coated Tablet Active Ingredients Ibuprofen, Pseudoephedrine Hydrochloride
Medicine Name Anadin Analgesic Tablets Active Ingredients Acetylsalicylic Acid, Caffeine
Medicine Name Anadin Maximum Strength Capsules Active Ingredients Acetylsalicylic acid (Aspirin), Caffeine
Medicine Name Andrews Liver Salts Effervescent Powder Active Ingredients Citric Acid (Anhydrous), Magnesium sulfate (dihydrate), Sodium Hydrogen Carbonate
Medicine Name Caltrate 500 mg / 1000 IU, chewable tablets Active Ingredients Calcium Carbonate, Colecalciferol (Vitamin D3)
Medicine Name Caltrate 600mg/400IU Film-coated Tablets Active Ingredients Calcium Carbonate, Vitamin D3
Medicine Name Corsodyl Aniseed 0.2% w/v Mouthwash Active Ingredients Chlorhexidine digluconate
Medicine Name Corsodyl 1% w/w Dental Gel Active Ingredients Chlorhexidine digluconate
Medicine Name Corsodyl Freshmint 0.2% w/v Mouthwash Active Ingredients Chlorhexidine digluconate
Medicine Name Corsodyl Mint 0.2% w/v Mouthwash Active Ingredients Chlorhexidine digluconate
Medicine Name Day Nurse Capsules Active Ingredients Paracetamol, Pholcodine, Pseudoephedrine Hydrochloride
Medicine Name Duofilm Cutaneous Solution Active Ingredients Lactic Acid, Salicylic Acid
Medicine Name Excedrin 250 mg /250 mg /65 mg film-coated tablets Active Ingredients Aspirin, Caffeine, Paracetamol
Medicine Name Flixonase Allergy Relief Nasal Spray Active Ingredients Fluticasone Propionate
Medicine Name Ibuprofen 200mg Soft Capsules Active Ingredients Ibuprofen
Medicine Name Lamisil 1% w/w Cream Active Ingredients Terbinafine hydrochloride
Medicine Name Lamisil AT Cream Active Ingredients Terbinafine hydrochloride
Medicine Name Lamisil Once 1% cutaneous solution Active Ingredients Terbinafine hydrochloride
Medicine Name Nicotinell Cool Mint 2mg medicated chewing gum Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Cool Mint 4mg medicated chewing gum Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Fruit 2mg medicated chewing-gums Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Fruit 4mg Medicated Chewing-Gums Active Ingredients Nicotine-polacrilin
Medicine Name Nicotinell Mint 1mg Compressed Lozenges Active Ingredients nicotine bitartrate dihydrate
Medicine Name Nicotinell Mint 2mg compressed Lozenges Active Ingredients nicotine bitartrate dihydrate
Medicine Name Nicotinell TTS 10, 7 mg/24 hour Transdermal Patch Active Ingredients Nicotine
1 - 0 of 57 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 3 May 2016 PIL

Reasons for updating

  • Change to MA holder contact details

Updated on 3 May 2016 PIL

Reasons for updating

  • New PIL for new product

Updated on 10 July 2015

Reasons for updating

  • New SmPC for new product

Legal category: Supply through general sale

Updated on 10 July 2015 SPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 7

Marketing Authorisation Holder address updated to:

12 Riverwalk,

Citywest Business Campus,

Dublin 24,

Ireland

Updated on 22 May 2015 SPC

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.8 - Addition of HPRA reporting statement

Updated on 21 May 2015 PIL

Reasons for updating

  • Change to side-effects

Updated on 3 December 2012 PIL

Reasons for updating

  • Change due to harmonisation of PIL

Updated on 13 August 2010 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to information about pregnancy or lactation

Updated on 24 August 2009 SPC

Reasons for updating

  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.3: Addition of hypersensitivity as a contraindication.
Section 4.4: Addition of warning re sugar intolerances.
Section 4.6: Addition of warnings re pergnancy.

Updated on 20 February 2009 SPC

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.3
the following text is added:
 

This product should not be given to patients with a hypersensitivity to any component of Andrews Liver Salts or any previous hypersensitivity to Andrews Liver Salts.

 
Section 4.4
the following text is added:
 

Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

Updated on 28 August 2007 PIL

Reasons for updating

  • Improved electronic presentation

Updated on 30 May 2007 PIL

Reasons for updating

  • Improved electronic presentation

Updated on 22 May 2007 SPC

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

6.5 Nature and Contents of Container

Removal of reference to 'integral 5 ml spoon'

Updated on 20 April 2007 SPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category: Supply through general sale

Free text change information supplied by the pharmaceutical company

1. Name of the medicinal product

Change name to: Andrews Liver Salts Effervescent Powder

6.4 Special Precautions for Storage

Amend wording as follows: Keep the container tightly closed.

6.5 Nature and Contents of Container

Include statement: Not all pack sizes may be marketed.

10. Date of revision of text

April 2007

Updated on 18 November 2004 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 20 August 2003 SPC

Reasons for updating

  • Improved electronic presentation

Legal category: Supply through general sale

Updated on 19 August 2003 SPC

Reasons for updating

  • Improved electronic presentation

Legal category: Supply through general sale

Updated on 12 August 2003 SPC

Reasons for updating

  • Improved electronic presentation

Legal category: Supply through general sale

Updated on 25 June 2003 SPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Supply through general sale